In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.

Fiche publication

Date publication

août 2019

Journal

Journal of translational medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr NGUYEN Philippe , Dr TERRYN Christine

Tous les auteurs :
Al-Rifai R, Nguyen P, Bouland N, Terryn C, Kanagaratnam L, Poitevin G, François C, Boisson-Vidal C, Sevestre MA, Tournois C

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31399109

Résumé

Cell therapy has been proposed for patients with critical limb ischemia (CLI). Autologous bone marrow derived cells (BMCs) have been mostly used, mesenchymal stem cells (MSCs) being an alternative. The aim of this study was to characterize two types of MSCs and evaluate their efficacy.